Lynk Solutec has been officially designated as an Innovative Product by the Public Procurement Service (PPS), marking a significant milestone for the company’s entry into the public procurement market and the expansion of its technology commercialization. This designation represents national recognition of the company’s technological capabilities and innovation.

The designated product is C.E.V. (Innovative Product Name: Endoscope Connector for Securing Clear Vision), a medical device component designed to prevent contamination from bodily fluids and foreign substances during endoscopic procedures, while ensuring clear visibility. Powered by Lynk Solutec’s proprietary coating technology, the product enhances procedural efficiency for medical professionals and improves patient safety.

This recognition is expected to strengthen Lynk Solutec’s competitiveness in the public procurement market while creating new opportunities for collaboration with medical and public institutions.

Moving forward, Lynk Solutec will continue to advance next-generation coating technologies and drive consistent quality innovation, with the goal of delivering tailored coating solutions optimized for clinical applications both domestically and globally.

Lynk Solutec Inc. participated in the “Lab-Thursday Talk” program hosted by Ewha Womans University Medical Center, presenting its latest medical coating technologies. The session was led by Dr. Yeontack Lee, CEO of Lynk Solutec, who introduced the company’s innovative coating solutions, their applications in medical devices, and potential directions for future collaborative research.

Lab-Thursday Talk is a regular program designed to foster collaboration between clinical and basic researchers and industry partners. Having been held more than 30 times, it has become a key platform for sharing research expertise and exploring opportunities for joint R&D projects.

Through this presentation, Lynk Solutec highlighted the innovation of its endoscopic coating technology and other medical device applications, while seeking opportunities for clinical collaboration and co-development. Moving forward, the company will continue to strengthen its research and development capabilities, expand its collaboration network with domestic and international medical institutions, and provide optimized coating solutions tailored to clinical needs.

Lynk Solutec has completed a U.S. patent application for its proprietary endoscopic coating technology, marking a significant milestone in the company’s efforts to expand into the global medical device market. This application follows the company’s domestic patent for its anti-fogging endoscopic coating agent and specialized certification, further validating the global applicability of Lynk Solutec’s innovative technology.

With this U.S. patent application, the company’s “Lynk Coating” technology has gained greater potential for adoption in the international medical device arena. Lynk Solutec plans to actively pursue global market expansion and technology licensing opportunities based on this advancement. The technology offers a groundbreaking solution that enhances surgical visibility and prevents the adhesion of biological substances, ultimately improving both procedural efficiency for medical professionals and safety for patients.

Looking ahead, Lynk Solutec aims to continue its growth in the global healthcare market through the development of next-generation coating technologies. The company is also committed to securing additional international certifications and strengthening global partnerships to ensure its solutions are widely adopted across diverse medical environments worldwide.